Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar
The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.
The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.